NCT03916523

Brief Summary

Neonatal respiratory distress syndrome (RDS) is the most common cause of respiratory failure in the first few days in life. It is characterized by the tendency of alveoli and terminal bronchioles to collapse due to the lack of surfactant. RDS is inversely related to gestational age and remains a dominant clinical problem encountered among preterm infants. The reduction in tidal volume secondary to alveolar collapse may result in alveolar derecruitment, cyclic opening and closing of atelectatic alveoli and distal small airways leading to inflammation and lung injury). On the other hand, the use of high positive end expiratory pressure (PEEP) may be associated with excessive lung parenchyma strain and unfavorable hemodynamic effects. Therefore, lung recruitment maneuvers have been proposed and used to open collapsed lung while managing with low pressure PEEP. However, the best recruitment maneuver technique is currently unknown. Proinflammatory cytokines are synthesized by alveolar macrophages, type II pneumocytes and other local pulmonary cells causing inflammation that starts a cascade leading to lung injury. Nevertheless, they are released systemically and can lead to injury of other organs. This study aims to measure inflammatory cytokines in the serum of premature infants who receive and do not receive sustained lung inflation. The study hypothesis is that, in premature infants supported with CPAP, the use of sustained inflation is associated with decreased inflammatory biomarkers and improved respiratory outcomes. The study includes infants with gestational age of 28-24 weeks during the first 6 hours of life who will be randomly assigned to either receive (or do not receive) sustained inflations. Serum concentrations of cytokines (IL-6, IL-8, IL-1β and TNF-α) will be measured at enrollment and at 96 hours. The primary outcome of this study will be the change in serum cytokine concentrations after intervention in both groups. Clinical respiratory outcomes will be monitored.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2013

Typical duration for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2013

Completed
3.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 15, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 15, 2016

Completed
3.1 years until next milestone

First Submitted

Initial submission to the registry

April 13, 2019

Completed
3 days until next milestone

First Posted

Study publicly available on registry

April 16, 2019

Completed
Last Updated

April 18, 2019

Status Verified

April 1, 2019

Enrollment Period

3.2 years

First QC Date

April 13, 2019

Last Update Submit

April 17, 2019

Conditions

Keywords

Sustained lung inflationLung injuryDelivery room managementCPAP

Outcome Measures

Primary Outcomes (1)

  • Serum concentration of cytokines

    IL-6, IL-8, IL-1β, - TNF-α and elastase will be measured in all subjects in group, group B, and group C.

    At 96 hours of life

Secondary Outcomes (1)

  • Oxygen requirement

    At 96 hours of life

Study Arms (3)

Group A

EXPERIMENTAL

Infants in the group receive CPAP for respiratory support in the delivery room. In addition, they receive a total of 15 sustained lung inflations in the first 96 hours of life; 6 in the first day, 3 in the second day, 3 in the third day and 3 in the forth day of life.

Procedure: Sustained lung inflation

Group B

EXPERIMENTAL

Infants in the group receive CPAP for respiratory support in the delivery room. No sustained lung inflation will be applied.

Procedure: Continuous positive airway pressure (CPAP)

Group C

ACTIVE COMPARATOR

Infants in this group are intubated in the delivery room and supported with mechanical ventilation.

Procedure: Mechanical ventilation

Interventions

Preterm infants will receive a total of 15 sustained lung inflations during the first 4 days of life as follows: 1. On day 1 of life (a total of 6 sustained lung inflations, 20 cmH2O for 21 seconds each) once at enrollment and then once every 4 hours 2. On day 2 of life (a total of 3 sustained lung inflations, 15 cmH2O for 21 seconds each) once every 8 hours. 3. On day 3 of life (a total of 3 sustained lung inflations 10cmH2O for 21 seconds each) once every 8 hours. 4. On day 4 of life (a total of 3 sustained lung inflations 10cmH2O for 21 seconds each) once every 8 hours.

Group A

Preterm infants will receive CPAP for respiratory support.

Also known as: CPAP
Group B

Preterm infants in this group will receive mechanical ventilation for respiratory support

Group C

Eligibility Criteria

AgeUp to 6 Hours
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Gestational age between 28 weeks (and 0 days) and 34 weeks (and 6 days)
  • Postnatal age \<6 hours
  • Respiratory distress syndrome diagnosed by both clinical findings of subcostal retractions, tachypnea (\>70 breaths/min), the need for respiratory support to maintain oxygen saturation \> 87% and X-ray findings of RDS
  • Application of early CPAP \<6 hours of age
  • Oxygen requirement (FiO2 \>30% to maintain preductal saturation 87% - 93%)

You may not qualify if:

  • Before enrollment: infants will not be considered in the study if any of the following conditions exists: major congenital anomalies, severe hemodynamic instability indicative of early septicemia, use of inotropes, severe metabolic acidemia with base deficit \>12 mEq/dl, frequent apnea / bradycardia (6 episodes per day with HR \<100 or 2 episodes per day with HR\<60 requiring bag-and-mask ventilation), maternal chorioamnionitis (fever \>38 degree Celsius with abdominal tenderness) and PPROM \>18 hours, and perinatal hypoxia (Apgar score \< 6 at 5 minutes)
  • After enrollment: infants will be eliminated from the study if the initial blood culture on admission is positive.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (4)

  • Abdel-Hady H, Shouman B, Aly H. Early weaning from CPAP to high flow nasal cannula in preterm infants is associated with prolonged oxygen requirement: a randomized controlled trial. Early Hum Dev. 2011 Mar;87(3):205-8. doi: 10.1016/j.earlhumdev.2010.12.010. Epub 2011 Jan 26.

    PMID: 21276671BACKGROUND
  • Aly H. Ventilation without tracheal intubation. Pediatrics. 2009 Aug;124(2):786-9. doi: 10.1542/peds.2009-0256. Epub 2009 Jul 27. No abstract available.

    PMID: 19651592BACKGROUND
  • Attar MA, Donn SM. Mechanisms of ventilator-induced lung injury in premature infants. Semin Neonatol. 2002 Oct;7(5):353-60. doi: 10.1053/siny.2002.0129.

    PMID: 12464497BACKGROUND
  • Lista G, Fontana P, Castoldi F, Cavigioli F, Dani C. Does sustained lung inflation at birth improve outcome of preterm infants at risk for respiratory distress syndrome? Neonatology. 2011;99(1):45-50. doi: 10.1159/000298312. Epub 2010 Jul 9.

    PMID: 20616570BACKGROUND

MeSH Terms

Conditions

Respiratory Distress Syndrome In Premature InfantsLung Injury

Interventions

Continuous Positive Airway PressureRespiration, Artificial

Condition Hierarchy (Ancestors)

Lung DiseasesRespiratory Tract DiseasesThoracic InjuriesWounds and Injuries

Intervention Hierarchy (Ancestors)

Positive-Pressure RespirationAirway ManagementTherapeuticsRespiratory TherapyResuscitationEmergency Treatment

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Masking Details
All laboratory testing will be performed by investigators who are not aware of group assignment.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Pediatrics

Study Record Dates

First Submitted

April 13, 2019

First Posted

April 16, 2019

Study Start

January 1, 2013

Primary Completion

March 15, 2016

Study Completion

March 15, 2016

Last Updated

April 18, 2019

Record last verified: 2019-04

Data Sharing

IPD Sharing
Will not share